The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Chemistry and Biology

• Publication date

  2008-02-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chembiol.2007.12.012PMID 18291315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases.

  2007influential reference
• Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

  2007cited by this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cited by this paper
• Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.

  2007influential reference
• On the nature of cavities on protein surfaces: Application to the identification of drug‐binding sites

  2006influential reference
• Features of selective kinase inhibitors.

  2005influential reference
• Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.

  2005influential reference
• The conformational plasticity of protein kinases.

  2002cited by this paper
• The Protein Kinase Complement of the Human Genome

  2002cited by this paper
• Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme

  2001influential reference
• Strategies toward the design of novel and selective protein tyrosine kinase inhibitors.

  1999influential reference
• Recognition of spatial motifs in protein structures.

  1999cited by this paper
• Protein kinase CK2 and its role in cellular proliferation, development and pathology

  1999cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Raster3D: photorealistic molecular graphics.

  1997cited by this paper
• An extensively modified version of MolScript that includes greatly enhanced coloring capabilities.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle

  1995cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated beta-subunits.

  1993cited by this paper
• Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1.

  1990cited by this paper
• BRAGI: a comprehensive protein modeling program system

  1988cited by this paper
• A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors.

  1974cited by this paper

• Binding‐Site Switch for Protein Kinase CK2 Inhibitors

  2025cites this paper
• A CK2α′ mutant indicating why CK2α and CK2α′, the isoforms of the catalytic subunit of human protein kinase CK2, deviate in affinity to CK2β

  2025influential citation
• Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer’s Disease

  2025cites this paper
• Effect of histidine protonation state on ligand binding at the ATP-binding site of human protein kinase CK2

  2024cites this paper
• Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold.

  2024cites this paper
• Enhanced inhibitory activity of compounds containing purine scaffolds compared to protein kinase CK2α considering crystalline water.

  2024cites this paper
• Recent Advances in the Discovery of CK2 Inhibitors

  2024cites this paper
• Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects.

  2023cites this paper
• Qualitative Estimation of Protein–Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations

  2022cites this paper
• Protein kinase CK2 inhibition as a pharmacological strategy.

  2021cites this paper
• Allosteric Type and Pathways Are Governed by the Forces of Protein-Ligand Binding.

  2021cites this paper
• Chemical probes targeting the kinase CK2: a journey outside the catalytic box.

  2021cites this paper
• Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study

  2021cites this paper
• Halogen Atoms in the Protein–Ligand System. Structural and Thermodynamic Studies of the Binding of Bromobenzotriazoles by the Catalytic Subunit of Human Protein Kinase CK2

  2021cites this paper
• CFTR fragments with the F508 deletion exert a dual allosteric control over the master kinase CK2.

  2020cites this paper
• Pharmacophore development, drug-likeness analysis, molecular docking, and molecular dynamics simulations for identification of new CK2 inhibitors

  2020cites this paper
• Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design

  2020cites this paper
• Structural and mechanistic basis of the inhibitory potency of selected 2-aminothiazole compounds on protein kinase CK2.

  2020cites this paper
• Computational Analysis of Crystallization Additives for the Identification of New Allosteric Sites

  2020cites this paper
• Unexpected CK2 beta-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.

  2020cites this paper
• Crystal structure of Arabidopsis thaliana casein kinase 2 α1.

  2020influential citation
• Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.

  2020cites this paper
• 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. Part 2: Structure–based optimization and investigation of effects specific to the allosteric mode of action

  2020cites this paper
• Structural analysis of fungal pathogenicity-related casein kinase α subunit, Cka1, in the human fungal pathogen Cryptococcus neoformans

  2019cites this paper
• Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites.

  2019cites this paper
• Design of CK2β‐Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells

  2019cites this paper
• 2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.

  2019cites this paper
• Small molecule modulators targeting protein kinase CK1 and CK2.

  2019cites this paper
• Molecular dynamics simulations reveal structural insights into inhibitor binding modes and mechanism of casein kinase II inhibitors

  2019cites this paper
• Protein Allostery in Rational Drug Design.

  2019cites this paper
• Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors

  2019cites this paper
• Novel non-ATP competitive small molecules targeting the CK2 α/β interface

  2018cites this paper
• Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies

  2018cites this paper
• Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.

  2018cites this paper
• A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods

  2017cites this paper
• In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface

  2017influential citation
• A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066

  2017cites this paper
• CaMKII Regulates Synaptic NMDA Receptor Activity of Hypothalamic Presympathetic Neurons and Sympathetic Outflow in Hypertension

  2017cites this paper
• ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2

  2017cites this paper
• Casein kinases as potential therapeutic targets

  2016cites this paper
• Mass Spectrometry Reveals Protein Kinase CK2 High-Order Oligomerization via the Circular and Linear Assembly.

  2016cites this paper
• Dynamic profile analysis to characterize dynamics-driven allosteric sites in enzymes

  2016cites this paper
• Beeinflussung der heterotetrameren Struktur der anti-apoptotischen Proteinkinase CK2 als potentielle pharmakologische Strategie

  2016influential citation
• Protéine-kinases et cancer du rein : Découverte et validation d’une nouvelle combinaison d’inhibiteurs ciblant les protéine-kinases ATM et CK2

  2016cites this paper
• Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2α/CK2β: comparative molecular dynamics simulation studies.

  2016cites this paper
• A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures.

  2015cites this paper
• Allosteric sites can be identified based on the residue–residue interaction energy difference

  2015cites this paper
• Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction.

  2015cites this paper
• Structural Basis for Low‐Affinity Binding of Non‐R2 Carboxylate‐Substituted Tricyclic Quinoline Analogs to CK2α: Comparative Molecular Dynamics Simulation Studies

  2015cites this paper
• Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α.

  2015cites this paper
• Screening of DTP Compound Libraries for CK2 Inhibitors with Focus on Natural Products

  2015cites this paper
• Impressions from the Conformational and Configurational Space Captured by Protein Kinase CK2

  2015cites this paper
• Benzimidazole-biologically attractive scaffold for protein kinase inhibitors

  2014cites this paper
• Harnessing Allostery: A Novel Approach to Drug Discovery

  2014cites this paper
• Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential

  2014cites this paper
• Evidence for aggregation of protein kinase CK2 in the cell: a novel strategy for studying CK2 holoenzyme interaction by BRET2

  2014cites this paper
• Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

  2014cites this paper
• The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.

  2014cites this paper
• Kinase CK2 inhibition: an update.

  2013cites this paper
• Development Of Kinase Catalyzed Biotinylation To Study Phosphoproteomics

  2013influential citation
• Structure of the Toxoplasma gondii ROP18 Kinase Domain Reveals a Second Ligand Binding Pocket Required for Acute Virulence*

  2013cites this paper
• Structural Bases of Protein Kinase CK2 Function and Inhibition

  2013cites this paper
• First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand.

  2013cites this paper
• Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model

  2013cites this paper
• Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2.

  2012cites this paper
• Protein kinase CK2 inhibitors: a patent review

  2012cites this paper
• Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias.

  2012cites this paper
• Quelques exemples de biologie structurale.Mécanismes de reconnaissance et de signalisation de l’hôte face aux pathogènes et au soi-altéré ; recherche de nouvelles molécules thérapeutiques

  2012cites this paper
• Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α′

  2011cites this paper
• The dark side of protein kinase CK2 inhibition.

  2011cites this paper
• Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.

  2011cites this paper
• Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface.

  2011cites this paper
• Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases

  2011cites this paper
• A detailed thermodynamic profile of cyclopentyl and isopropyl derivatives binding to CK2 kinase

  2011cites this paper
• Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.

  2011cites this paper
• Structural basis of CX‐4945 binding to human protein kinase CK2

  2011cites this paper
• Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.

  2010cites this paper
• Development and study of inhibitors of heat shock protein 70 induction

  2010cites this paper
• Halogen bonds form the basis for selective P-TEFb inhibition by DRB.

  2010cites this paper
• Régulation du facteur de transcription SNAIL1 au cours de la transition épithélio-mésenchymateuse dans les cellules mammaires MCF10A : implication de la protéine-kinase CK2

  2010cites this paper
• New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights

  2010cites this paper
• How druggable is protein kinase CK2?

  2010cites this paper
• Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2.

  2010cites this paper
• Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.

  2010cites this paper
• Resorufin: a lead for a new protein kinase CK2 inhibitor

  2009cites this paper
• Structure of human protein kinase CK2 alpha 2 with a potent indazole-derivative inhibitor.

  2009cites this paper
• Protein Kinase CK2 in Health and Disease

  2009cites this paper
• Protein Kinase CK2 in Health and Disease

  2009cites this paper
• Structural bases of protein kinase CK2 inhibition

  2009cites this paper
• α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells*

  2009cites this paper
• Protein Kinase CK2 in Health and Disease

  2009cites this paper
• Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library

  2009cites this paper
• Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.

  2009cites this paper
• New protein kinase CK2 inhibitors: jumping out of the catalytic box.

  2009cites this paper
• Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.

  2009cites this paper
• First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.

  2009cites this paper
• Protein Kinase CK2 in Health and Disease

  2009cites this paper
• The interaction of CK2α and CK2β, the subunits of protein kinase CK2, requires CK2β in a preformed conformation and is enthalpically driven

  2008cites this paper
• Protein kinase CK2 in human diseases.

  2008cites this paper
• A casein kinase 2 inhibitor is a potent anti-cancer drug candidate

  2008cites this paper